Anti-malaria MAb in Malian Children

NCT05304611 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

365

Enrollment

NIH

Sponsor class

Conditions

Plasmodium Falciparum Infection
Malaria

Interventions

BIOLOGICAL: L9LS (VRC-MALMAB0114-00-AB) Subcutaneous injection
BIOLOGICAL: L9LS (VRC-MALMAB0114-00-AB) intravenous injection
OTHER: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]